首页 | 本学科首页   官方微博 | 高级检索  
     

肾纤维化发病机制及治疗学研究进展
引用本文:辛冰牧,杨红振,胡卓伟. 肾纤维化发病机制及治疗学研究进展[J]. 国际药学研究杂志, 2008, 35(5): 349-354
作者姓名:辛冰牧  杨红振  胡卓伟
作者单位:中国医学科学院/北京协和医科大学药物研究所,北京,100050
基金项目:国家自然科学基金  
摘    要:
肾纤维化以过量细胞外基质在肾间质积聚、肾脏组织结构破坏及功能丧失为特征,是多种慢性肾脏疾病最终导致肾功能衰竭的主要病理改变和共同通路。肾纤维化产生的原因在于内外致病原引起的肾组织损伤及损伤后的修复失调。肾纤维化涉及炎症反应、肾脏固有细胞及免疫细胞凋亡、氧化应激反应增强、促/抑纤维化细胞因子失衡等多个环节。因此,主要通过抑制或阻断炎症、抗凋亡、抗氧化应激、调节肾组织局部免疫微环境等途径开发抗肾纤维化的药物。本文综述了近年来有关肾纤维化发病机制,特别是相关药物新靶点及治疗学的研究进展。

关 键 词:肾纤维化; 肾炎   间质性; 肾功能不全  慢性; 肾脏用药; 吡非尼酮
收稿时间:2008-02-26

Research progress on the pathogenesis and therapeutics of renal fibrosis
XIN Bing-mu,YANG Hong-zhen,HU Zhuo-wei. Research progress on the pathogenesis and therapeutics of renal fibrosis[J]. Foreign Medical Sciences(Section of Pharmarcy), 2008, 35(5): 349-354
Authors:XIN Bing-mu  YANG Hong-zhen  HU Zhuo-wei
Affiliation:(Institute of Materia Medica, Chinese Academy of Medical Sciences &; Peking Union Medical College, Beijing 100050, China)
Abstract:
Renal fibrosis is a common consequence of chronic kidney diseases that leads to chronic renal failure. The pathological characteristics of renal fibrosis is disproportionate accumulation of extracellular matrix that replaces kidney parenchyma, ultimately leading to renal destruction and dysfunction. Several pathways are involved in renal fibrosis, such as inflammation, apoptosis of renal cells, infiltrated immune cells, oxide stress and imbalance of relocated cytokines. Here, we review the pathogenesis of renal fibrosis, and research progress in the novel targets and promising therapeutic strategies.
Keywords:renal fibrosis  nephritis  interstitial  renal insufficiency  chronic  renal agents  pirfenidone
本文献已被 维普 万方数据 等数据库收录!
点击此处可从《国际药学研究杂志》浏览原始摘要信息
点击此处可从《国际药学研究杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号